Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Studies gut bacteria over time in people with chronic heart failure

Follows gut bacteria and body changes in adults with weakened-heart failure over time.

Plain-language title generated from the registry record
Registry title: Gut Microbiome Profiling in Patients With Chronic Heart Failure

Key facts

Where
Stanford, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06361524, who can take part

Where in United States

  • Stanford UniversityStanford, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Stanford University
Trial code
NCT06361524
Record updated
16 May 2025
Original description
The goal of this observational study is to learn about the composition and function of the gut microbiome in adults with chronic heart failure with reduced ejection fraction. The main questions the study aims to answer are:Read full original descriptionShow less

Longitudinal Gut Microbiome and Host Multi-omic Profiling in Patients With Chronic Heart Failure

The goal of this observational study is to learn about the composition and function of the gut microbiome in adults with chronic heart failure with reduced ejection fraction. The main questions the study aims to answer are:

1. How does the gut microbiome and its interactions with the host change over time in adults with chronic heart failure? 2. How do these changes relate to heart failure disease severity and complications?

Inclusion: Heart failure with reduced ejection fraction (left ventricular ejection fraction less than 50%); Non-ischemic cardiomyopathy; Body mass index (BMI) 18-40 kg/m2.

Exclusion: Current or recent (within 4 weeks) use of systemic antibiotics, commercial probiotics, immunosuppressive or immunomodulatory medications; Treated diabetes; Advanced kidney disease; Significant gastrointestinal disease including any history of inflammatory bowel disease; History of extensive bowel resection; Active malignancy or systemic chemotherapy within the past 12 months; Active infection; Cirrhosis; Pregnancy/lactation.

ClinicalTrials.gov NCT06361524